Advertisement
Abstract

Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.

P S Pagel, C P Harkin, D A Hettrick and D C Warltier
Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 127-135;

Article Information

vol. 275 no. 1 127-135
PubMed 
7562540
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online October 1, 1995.

Author Information

  1. P S Pagel,
  2. C P Harkin,
  3. D A Hettrick and
  4. D C Warltier
  1. Department of Pharmacology, Medical College of Wisconsin, Milwaukee, USA.

Statistics from Altmetric.com

Article usage

Article usage: January 1999 to December 2024

AbstractFullPdf
Jan 1999100
Jul 1999100
Jan 2000100
Jun 2000100
May 2001300
Mar 2002200
May 2002100
Jul 2003500
Aug 2003200
Sep 2003300
Oct 2003200
Nov 2003300
Dec 2003300
Jan 2004300
Feb 2004700
Mar 2004600
Apr 20041100
May 20041100
Jun 20041000
Jul 2004900
Aug 20041400
Sep 20041200
Oct 2004900
Nov 20041100
Dec 2004800
Jan 20051100
Feb 2005400
Mar 20051000
May 2005200
Jun 2005200
Jul 2005200
Sep 2005100
Oct 2005500
Dec 2005200
Feb 2006100
Mar 2006100
Apr 2006002
May 2006001
Jun 2006100
Jul 2006301
Aug 2006001
Sep 2006100
Oct 2006200
Nov 2006002
Dec 2006401
Jan 2007202
Feb 2007100
Mar 2007100
Apr 2007200
May 2007100
Aug 2007400
Oct 2007001
Nov 2007001
Dec 2007302
Jan 2008004
Feb 2008300
Mar 2008100
Apr 2008100
May 2008500
Jul 2008200
Aug 2008300
Sep 2008800
Oct 2008101
Nov 2008500
Dec 2008100
Jan 2009100
Mar 2009003
Apr 2009201
May 2009300
Jul 2009201
Aug 2009100
Sep 2009300
Oct 2009500
Nov 2009300
Dec 2009400
Jan 2010500
Feb 2010500
Mar 2010202
Apr 2010400
May 2010200
Jun 2010100
Jul 2010102
Aug 2010200
Sep 2010400
Dec 2010200
Jan 2011100
Feb 2011100
Mar 2011200
Apr 2011200
May 2011701
Jun 2011400
Jul 2011400
Aug 2011600
Sep 2011200
Oct 2011200
Nov 2011800
Dec 2011500
Jan 2012500
Feb 2012900
Mar 2012801
Apr 2012600
May 2012600
Jun 2012402
Jul 2012501
Aug 2012203
Sep 2012100
Oct 2012200
Nov 2012202
Feb 2013400
Mar 2013200
Apr 2013300
May 2013200
Jun 2013103
Jul 2013300
Aug 2013100
Sep 20131702
Oct 2013301
Nov 2013301
Dec 2013100
Feb 2014302
Mar 2014001
Apr 2014200
May 2014001
Jun 2014001
Jul 2014400
Oct 2014201
Nov 2014100
Jan 2015301
Feb 2015200
Mar 2015100
Jul 2015200
Aug 2015100
Sep 2015100
Oct 2015200
Dec 2015700
Jan 2016101
Mar 2016500
Apr 2016001
May 2016200
Jun 2016100
Jul 2016100
Sep 2016300
Oct 20161001
Nov 2016800
Dec 2016400
Feb 2017300
Mar 2017400
Apr 2017200
May 2017100
Jun 2017903
Jul 2017100
Aug 2017101
Sep 2017400
Oct 2017300
Nov 2017300
Dec 2017200
Jan 2018200
Feb 2018300
Mar 2018400
Apr 20181000
May 2018700
Jun 2018600
Jul 2018300
Aug 2018200
Sep 2018100
Oct 2018500
Nov 20181100
Dec 2018300
Jan 2019900
Feb 20191500
Mar 2019400
Apr 2019500
May 2019402
Jun 2019100
Jul 2019200
Aug 2019400
Sep 2019900
Oct 2019800
Nov 20191100
Dec 2019500
Jan 2020600
Feb 2020600
Mar 2020100
Apr 2020200
May 20201202
Jun 2020200
Jul 2020200
Aug 2020100
Sep 2020300
Oct 2020200
Nov 2020401
Dec 20201400
Jan 20212900
Feb 2021800
Mar 20211000
Apr 20211100
May 20212700
Jun 2021300
Jul 20211200
Aug 2021500
Sep 2021400
Oct 2021400
Nov 20212200
Dec 2021600
Jan 2022600
Feb 2022300
Mar 2022200
Apr 2022800
May 2022400
Jun 2022800
Jul 20221500
Aug 2022800
Sep 20221700
Oct 2022500
Nov 2022500
Dec 2022300
Jan 2023900
Feb 20231000
Mar 2023400
Apr 2023800
May 20231000
Jun 2023200
Jul 20231000
Aug 2023600
Sep 2023400
Oct 2023400
Dec 20231200
Jan 20241300
Feb 2024600
Mar 20241100
Apr 20241000
May 2024500
Jun 20241300
Jul 2024700
Aug 20241700
Sep 2024601
Oct 2024700
Nov 2024100
Dec 2024100

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Abstract

Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.

P S Pagel, C P Harkin, D A Hettrick and D C Warltier
Journal of Pharmacology and Experimental Therapeutics October 1, 1995, 275 (1) 127-135;
Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

Cited By...

Similar Articles

Advertisement